Regulation And Legal
Shukra Medtech Confirms No Preferential Issue Fund Deviation
Shukra Medtech Limited files SEBI Regulation 32(1) compliance disclosure confirming no deviation in utilization of ₹10.46 crore preferential issue proceeds.
Company raised ₹10.46 crore through 46.43 l
